Bullish
WHWK: Innovative ADC platform shows strong clinical progress and industry validation for oncology targets
Whitehawk Therapeutics, Inc. (WHWK) is advancing a differentiated Antibody-Drug Conjugate (ADC) platform with three clinical-stage assets. The platfor...